Calago, Marlyn C.
HRN: 12-38-18 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/07/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/07/2024
07/14/2024
IV
2.25g
Q 8hrs
CAP-HR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes